Literature DB >> 8627687

Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

X S Wang1, S Ponnazhagan, A Srivastava.   

Abstract

The adeno-associated virus type 2 (AAV) genome can be successfully rescued from recombinant plasmids following transfection in adenovirus-infected human cells. However, following rescue, the AAV genome undergoes preferential replication and encapsidation, whereas little replication and packaging of the vector DNA sequences occur. In view of the crucial role in the rescue, replication, and packaging of the proviral genome played by the AAV inverted terminal repeats (ITRs), which consist of a palindromic hairpin (HP) structure and a 20-nucleotide stretch, designated the D-sequence, that is not involved in the HP-formation, we evaluated the involvement of the individual ITRs as well as their components in the selective viral DNA replication and encapsidation. A number of recombinant AAV plasmids that contained deletions-substitutions in different regions of the individual ITRs were constructed and examined for their potential to allow rescue, replication, and/or packaging in adenovirus-infected human cells in vivo. The results reported here document that (ii) two HP structures and one D-sequence are sufficient for efficient rescue and preferential replication of the AAV DNA, (ii) two HP structures alone allow a low-level rescue and replication of the AAV DNA, but rescue and replication of the vector DNA sequences also occur in the absence of the D-sequences, (iii) one HP structure and two D-sequences, but not one HP structure and one D-sequence, also allow rescue and replication of the AAV as well as the vector DNA sequences, (iv) one HP structure alone or two D-sequences, but not one D-sequence alone, allow replication of the full-length plasmid DNA, but no rescue of the AAV genome occurs, (v) no rescue-replication occurs in the absence of the HP structures and the D-sequences, (vi) in the absence of the D-sequences, the HP structures are insufficient for successful encapsidation of the AAV genomes, and (vii) the AAV genomes containing only one ITR structure can be packaged into biologically active virions. Thus, the D-sequence plays a crucial role in the efficient rescue and selective replication and encapsidation of the AAV genome. Furthermore, the D-sequence specifically interacts with a hitherto unknown host-cell protein that we have designated the D-sequence-binding protein (D-BP). These studies illustrate that the D-sequence-D-BP interaction constitutes an important step in the AAV life cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627687      PMCID: PMC189990     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Adeno-associated virus autointerference.

Authors:  B J Carter; C A Laughlin; L M de la Maza; M Myers
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV.

Authors:  R J Samulski; A Srivastava; K I Berns; N Muzyczka
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

3.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

4.  Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA.

Authors:  E Lusby; K H Fife; K I Berns
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

5.  Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function.

Authors:  J D Tratschin; I L Miller; B J Carter
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

6.  Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells.

Authors:  A K Cheung; M D Hoggan; W W Hauswirth; K I Berns
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

7.  Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.

Authors:  R J Samulski; K I Berns; M Tan; N Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.

Authors:  P L Hermonat; N Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  Replication of adeno-associated virus DNA. Complementation of naturally occurring rep- mutants by a wild-type genome or an ori- mutant and correction of terminal palindrome deletions.

Authors:  P Senapathy; J D Tratschin; B J Carter
Journal:  J Mol Biol       Date:  1984-10-15       Impact factor: 5.469

10.  In vitro replication of duplex circular DNA containing the simian virus 40 DNA origin site.

Authors:  C R Wobbe; F Dean; L Weissbach; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more
  43 in total

1.  Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size.

Authors:  G E Tullis; T Shenk
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector.

Authors:  Arun Srivastava
Journal:  Hum Gene Ther       Date:  2016-01       Impact factor: 5.695

3.  Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.

Authors:  S Weger; A Wistuba; D Grimm; J A Kleinschmidt
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  A role for single-stranded templates in cell-free adeno-associated virus DNA replication.

Authors:  P Ward; R M Linden
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

8.  Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb.

Authors:  Yi Lai; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

9.  Co-Delivery of a Short-Hairpin RNA and a shRNA-Resistant Replacement Gene with Adeno-Associated Virus: An Allele-Independent Strategy for Autosomal-Dominant Retinal Disorders.

Authors:  Michael T Massengill; Brianna M Young; Alfred S Lewin; Cristhian J Ildefonso
Journal:  Methods Mol Biol       Date:  2019

10.  Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication.

Authors:  Peter Ward; Per Elias; R Michael Linden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.